MLchartDataset catalogue

Ro 50-3821

Term · Oncology and biomedicine · MLC-T-ONC-007482

A substance that is being studied in the treatment of anemia in patients who are receiving chemotherapy. It is a form of erythropoietin (a substance produced in the kidneys that stimulates the production of red blood cells) that has been changed in the laboratory. Also called methoxypolyethylene glycol epoetin beta.

Table 1. Record
IdentifierMLC-T-ONC-007482
FieldOncology and biomedicine
Synonymsmethoxypolyethylene glycol epoetin beta
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-007482",
  "term": "Ro 50-3821",
  "field": "Oncology and biomedicine",
  "definition": "A substance that is being studied in the treatment of anemia in patients who are receiving chemotherapy. It is a form of erythropoietin (a substance produced in the kidneys that stimulates the production of red blood cells) that has been changed in the laboratory. Also called methoxypolyethylene glycol epoetin beta.",
  "synonyms": [
    "methoxypolyethylene glycol epoetin beta"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ro-50-3821/"
}

Record 14,543 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.